# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-21-021181
Filing Date
2021-04-12
Accepted
2021-04-12 16:05:34
Documents
3
Period of Report
2021-05-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | ea139206-def14a_citiuspharma.htm | DEF 14A | 298778
2 | GRAPHIC | proxy_001.jpg | GRAPHIC | 396910
3 | GRAPHIC | proxy_002.jpg | GRAPHIC | 221380
| Complete submission text file | 0001213900-21-021181.txt |  | 1151545

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38174 | Film No.: 21820779
SIC: 2834 Pharmaceutical Preparations